Original Source(s)
Related Content
FDA expands treatment in nephrotic syndrome
The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.
September 28, 2026
-
2 min
Enterovirus diversity may limit treatment advances
Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.
September 8, 2026
-
4 min
First MCT8 deficiency therapy approved
Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.
September 29, 2026
-
3 min
